Basma Adeem Medical Co. vs Dallah Healthcare Co.
A head-to-head of Basma Adeem Medical Co. (9626) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 9626 | 4004 |
|---|---|---|
| Market Cap | 118.00M SAR | 10.78B SAR |
| P/E (TTM) | 15.03 | 20.02 |
| Forward P/E | — | 20.80 |
| P/S | 2.60 | 2.67 |
| P/B | 2.61 | 2.64 |
| EV/EBITDA | 9.19 | 20.79 |
| Dividend Yield | — | 1.79% |
| Profit Margin | 16.07% | 11.15% |
| Gross Margin | 29.30% | 35.71% |
| Operating Margin | 17.78% | 15.40% |
| Revenue Growth (YoY) | +44.10% | +21.68% |
| FCF Yield | — | -0.21% |
| Debt / Equity | 30.99 | 94.09 |
| Current Ratio | 6.55 | 1.20 |
Which is better: Basma Adeem Medical Co. or Dallah Healthcare Co.?
- ✓Larger by market cap: Dallah Healthcare Co.
- ✓Cheaper valuation (lower P/E): Basma Adeem Medical Co.
- ✓More profitable (net margin): Basma Adeem Medical Co.
- ✓Faster revenue growth: Basma Adeem Medical Co.
Across 10 available metrics, Basma Adeem Medical Co. leads 9–1.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Basma Adeem Medical Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.